<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00065104</url>
  </required_header>
  <id_info>
    <org_study_id>R01AT000512-01</org_study_id>
    <secondary_id>AbramsD</secondary_id>
    <nct_id>NCT00065104</nct_id>
  </id_info>
  <brief_title>Dehydroepiandrosterone Effects on HIV-1 Replication</brief_title>
  <official_title>Dehydroepiandrosterone Effects on HIV-1 Replication</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>National Center for Complementary and Integrative Health (NCCIH)</agency>
      <agency_class>NIH</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>National Center for Complementary and Integrative Health (NCCIH)</source>
  <brief_summary>
    <textblock>
      This study's purpose is to learn how dehydroepiandrosterone (DHEA) affects the HIV virus, the
      immune system, hormone levels, body composition and quality of life.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>October 2000</start_date>
  <completion_date>April 2003</completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double</masking>
  </study_design_info>
  <enrollment>40</enrollment>
  <condition>HIV Infections</condition>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>DHEA</intervention_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion criteria:

          -  Evidence of HIV-1 infection

          -  HIV RNA &lt;50 copies/mL

          -  Stable antiretroviral treatment regimen for at least 8 weeks

          -  Age 18 years or older

          -  Normal pap smear and mammograph within 1 year (females)

          -  Normal prostate-specific antigen level with in one year, age adjusted (males)

        Exclusion criteria:

          -  Active opportunistic infections or malignancy other than localized cutaneous KS
             lesions

          -  Concurrent or prior use within the past 8 weeks of DHA, testosterone, other anabolic
             steroids, corticosteroids, megestrol acetate, growth hormone, IL-2, or thalidomide

          -  Diagnosis of AIDS Dementia Complex (stage II or higher)

          -  Active substance abuse (e.g., alcohol or injection drugs)

          -  Evidence of severe liver dysfunction or hepatic transaminases greater than 3x the
             upper normal limit

          -  Pregnant or breast-feeding

          -  History of endocrinologically-responsive tumors (e.g., breast, ovarian, uterine, or
             prostatic cancer, or malignant melanoma)
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Community Consortium</name>
      <address>
        <city>San Francisco</city>
        <state>California</state>
        <zip>94110</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>August 2006</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>July 17, 2003</study_first_submitted>
  <study_first_submitted_qc>July 17, 2003</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 18, 2003</study_first_posted>
  <last_update_submitted>August 16, 2006</last_update_submitted>
  <last_update_submitted_qc>August 16, 2006</last_update_submitted_qc>
  <last_update_posted type="Estimate">August 18, 2006</last_update_posted>
  <keyword>HIV</keyword>
  <keyword>DHEA</keyword>
  <keyword>immune system</keyword>
  <keyword>hormones</keyword>
  <keyword>body composition</keyword>
  <keyword>quality of life</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>HIV Infections</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Dehydroepiandrosterone</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

